151 related articles for article (PubMed ID: 37139247)
1. Cefepime Dosing in a Critically Ill Neonate Receiving Continuous Renal Replacement Therapy With the Cardio-Renal Pediatric Dialysis Emergency Machine (CARPEDIEM).
Toy C; Stimes G; Moore M; Srivaths P; Arikan AA
J Pediatr Pharmacol Ther; 2023; 28(2):167-171. PubMed ID: 37139247
[TBL] [Abstract][Full Text] [Related]
2. Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM).
Ronco C; Garzotto F; Brendolan A; Zanella M; Bellettato M; Vedovato S; Chiarenza F; Ricci Z; Goldstein SL
Lancet; 2014 May; 383(9931):1807-13. PubMed ID: 24856026
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
[TBL] [Abstract][Full Text] [Related]
4. Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study.
Chaijamorn W; Charoensareerat T; Srisawat N; Pattharachayakul S; Boonpeng A
J Intensive Care; 2018; 6():61. PubMed ID: 30221005
[TBL] [Abstract][Full Text] [Related]
5. CARPEDIEM® for continuous kidney replacement therapy in neonates and small infants: a French multicenter retrospective study.
Battista J; De Luca D; Eleni Dit Trolli S; Allard L; Bacchetta J; Bouhamri N; Enoch C; Faudeux C; Guichoux J; Javouhey E; Kolev K; Regiroli G; Ranchin B; Bernardor J
Pediatr Nephrol; 2023 Aug; 38(8):2827-2837. PubMed ID: 36625933
[TBL] [Abstract][Full Text] [Related]
6. Survival of infants treated with CKRT: comparing adapted adult platforms with the Carpediem™.
Goldstein SL; Vidal E; Ricci Z; Paglialonga F; Peruzzi L; Giordano M; Laforgia N; Ronco C
Pediatr Nephrol; 2022 Mar; 37(3):667-675. PubMed ID: 34414499
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.
Hoff BM; Maker JH; Dager WE; Heintz BH
Ann Pharmacother; 2020 Jan; 54(1):43-55. PubMed ID: 31342772
[No Abstract] [Full Text] [Related]
8. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
9. Applying Cefepime Population Pharmacokinetics to Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
Al-Shaer MH; Maguigan K; Ashton J; Venugopalan V; Droege ME; Philpott CD; Droege CA; Healy DP; Mueller EW; Peloquin CA
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0161121. PubMed ID: 34662194
[TBL] [Abstract][Full Text] [Related]
10. Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.
Kalaria S; Williford S; Guo D; Shu Y; Medlin C; Li M; Yeung SYA; Ali F; Jean W; Gopalakrishnan M; Heavner M
Pharmacotherapy; 2021 Feb; 41(2):205-211. PubMed ID: 33438291
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.
Dubinsky S; Watt K; Saleeb S; Ahmed B; Carter C; Yeung CHT; Edginton A
Clin Pharmacokinet; 2022 Feb; 61(2):189-229. PubMed ID: 34846703
[TBL] [Abstract][Full Text] [Related]
12. Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement Therapy.
Al-Shaer MH; Philpott CD; Droege CA; Courter JD; Healy DP; Droege ME; Ernst NE; Mueller EW; Peloquin CA
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722885
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam dosing in patients receiving continuous renal replacement therapy.
Chaijamorn W; Charoensareerat T; Rungkitwattanakul D; Phunpon S; Sathienluckana T; Srisawat N; Pattharachayakul S
Epilepsia; 2021 Sep; 62(9):2151-2158. PubMed ID: 34247386
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.
Wenzler E; Butler D; Tan X; Katsube T; Wajima T
Clin Pharmacokinet; 2022 Apr; 61(4):539-552. PubMed ID: 34792787
[TBL] [Abstract][Full Text] [Related]
15. A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
Jang SM; Gharibian KN; Lewis SJ; Fissell WH; Tolwani AJ; Mueller BA
J Clin Pharmacol; 2018 Oct; 58(10):1254-1265. PubMed ID: 29746711
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of continuous-infusion acylovir for disseminated herpes simplex virus infection in a neonate receiving concurrent extracorporeal life support and continuous renal replacement therapy.
Cies JJ; Moore WS; Miller K; Small C; Carella D; Conley S; Parker J; Shea P; Chopra A
Pharmacotherapy; 2015 Feb; 35(2):229-33. PubMed ID: 25556960
[TBL] [Abstract][Full Text] [Related]
17. Cefepime Pharmacokinetics in Critically Ill Pediatric Patients Receiving Continuous Renal Replacement Therapy.
Stitt G; Morris J; Schmees L; Angelo J; Akcan Arikan A
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718247
[TBL] [Abstract][Full Text] [Related]
18. An optimal extended-infusion dosing of cefepime and ceftazidime in critically ill patients with continuous renal replacement therapy.
Sember AM; LoFaso ME; Lewis SJ
J Crit Care; 2022 Jun; 69():154011. PubMed ID: 35202996
[TBL] [Abstract][Full Text] [Related]
19. Cefepime Extraction by Extracorporeal Life Support Circuits.
Green DJ; Watt KM; Fish DN; McKnite A; Kelley W; Bensimhon AR
J Extra Corpor Technol; 2022 Sep; 54(3):212-222. PubMed ID: 36742220
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
